FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 169 filers reported holding FATE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 9.78 and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $7,163,616 | 2.64% |
| Redmile Group, LLC | 13,124,427 | $27,823,785 | 1.32% |
| Monaco Asset Management SAM | 1,847,944 | $3,917,641 | 1.16% |
| Casdin Capital, LLC | 2,050,000 | $4,346,000 | 0.48% |
| TANG CAPITAL MANAGEMENT LLC | 700,000 | $1,484,000 | 0.21% |
| GCM Grosvenor Holdings, LLC | 495,916 | $1,051,342 | 0.21% |
| Nebula Research & Development LLC | 163,617 | $346,868 | 0.18% |
| Bellevue Group AG | 4,851,579 | $10,285,347 | 0.17% |
| Bruce & Co., Inc. | 200,000 | $424,000 | 0.14% |
| XTX Topco Ltd | 192,920 | $408,990 | 0.07% |
| DARK FOREST CAPITAL MANAGEMENT LP | 425,901 | $902,910 | 0.07% |
| Parametrica Management Ltd | 18,472 | $39,161 | 0.07% |
| Boxer Capital, LLC | 500,000 | $1,060,000 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 253,429 | $537 | 0.05% |
| PDT Partners, LLC | 138,814 | $294,286 | 0.04% |
| Rock Springs Capital Management LP | 612,215 | $1,297,896 | 0.04% |
| Sciencast Management LP | 31,540 | $66,865 | 0.03% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 2,389,123 | $5,064,941 | 0.03% |
| HERBST GROUP, LLC | 15,700 | $33,284 | 0.02% |
| Virtus ETF Advisers LLC | 18,216 | $38,618 | 0.02% |
External links
This page lists FATE THERAPEUTICS INC's shareholders in Q3 2023. To view FATE THERAPEUTICS INC's shareholder history, click here.